Mark Pacala
DirectoratStarling Oncology· In proxies 2023–2025
Mark Pacala sits on 2 public boards.
Boards1
- Starling OncologyDirector · 3 yr on the boardIndependentAudit, Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Starling OncologyPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +331%
- Legacy TOIPublic company · 2 yr
- Director2018 – 2020 · 2 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?